MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X)) Recall

Ongoing
Medical Devices
Class II — Moderate

Recall Date

Sep 16, 2026

Company

Nipro Renal Soultions USA, Corporation

Source

FDA

Units

2,327 cases

Reason: Hemodialysis concentrates contain high endotoxin levels

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

Hemodialysis concentrates contain high endotoxin levels

Reason for Recall

Hemodialysis concentrates contain high endotoxin levels

What Should I Do?

Quantity: 2,327 cases

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated September 22, 2026

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.